Takeda Pharmaceutical

US · TAK #400 by market cap Listed 1970

18.37 +0.27 +1.49%

Live - 5344 symbols - heartbeat 5s ago · 2026-10-08 05:53

Pre-market 18.40 +0.16%

After-hours 18.37 0.00%

Overnight 18.34 -0.16%

Market cap: 58.68B
P/E (TTM): -55.67
P/B: 1.23
EPS: -0.31
Div yield: 3.26%
52W pos: 88%

Reader sentiment Are you bullish or bearish on TAK?

Anonymous reader poll. Unscientific, not investment advice.

About Takeda Pharmaceutical

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Founded: 1781
CEO: Ms. Julie Kim
Employees: 47,029
Headquarters: Osaka, Osaka, Japan
Fiscal year end: 03-31
Website: takeda.com

Company profile

Exchange: US
Symbol: TAK
Market-cap rank: #400
Listing date: 1970-01-01
Market cap: 58.68B
Float cap: 56.82B
Shares out: 3.19B
Float shares: 3.09B

Sectors & themes

Infectious Disease Drug Manufacturers - Specialty & Generic Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 05:53:46 · For reference only, not investment advice and not tailored to your situation.